Remove BioTech Remove Health Policy Remove Life Science Remove Survey
article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

Here, we call out the 12% increase in the proportion of Americans who say that parents should be able to choose not to vaccinate their children, found in the Kaiser Family Foundation COVID-19 Vaccine Monitor survey from December 2022.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

rank prescription drugs, lab tests, emergency room visits, dental and vision care, preventive services, chronic disease management and mental health care as the “most essential” health care services, according to the 2019 Survey of America’s Patients conducted by The Physicians Foundation. People in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Interestingly, these are two of the most prominent life science companies that have been part of Operation Warp Speed to accelerate the development of COVID-19 vaccines.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

Nine in ten Americans is concerned about the price of prescription drugs in the wake of the coronavirus pandemic, Gallup and West Health found in their survey on the cost of healthcare, published today. A majority of people across political party share this concern: overall, 88% of U.S. 84% of Republicans. 84% of Republicans.

BioTech 191
article thumbnail

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

KFF surveyed 1,440 adults 18 and over by phone between February 14th–24th 2019. Health Populi’s Hot Points: This week, Eli Lilly announced that they would introduce a generic form of Humalog , the company’s insulin product, at a price 50% lower than the brand.

article thumbnail

Consumers Consider Cost When They Think About Medical Innovation

Health Populi

” In the sample, two-thirds of respondents had seen a health care provider for an illness or medical condition in the past 12 months, so two-thirds of the survey sample have faced a medical encounter yielding some kind of medical bill in the past year. adults in April-May 2018 for this survey.

BioTech 120